Launch is not adoption.
The Adoption Diagnosis finds what blocks adoption of healthcare technologies before launch, after launch, and across a portfolio.
An adoption diagnostic for medical device, diagnostics, and digital health companies, and for the investors who back them.
Revenue tells you they bought it. Adoption tells you they kept using it.
Adoption is sustained, intentional, on-label use by its intended users. That is what the diagnosis measures.
Where are you?
Three situations, one diagnosis. Recognize yours and follow it.
Before Launch
You are about to commit the launch budget and cannot yet see whether adoption will follow. The Value Proposition Diagnostic tests whether your value story will carry the launch, before the money is spent.
After Launch
You have launched, and adoption is below plan or has stalled. The Adoption Read finds what is blocking it now, and where the next dollar should go.
Portfolio
You hold several companies and need to know where adoption risk concentrates. The Adoption Read prioritizes which asset to investigate first.
Who it is for
Commercial, marketing, product, and clinical leaders at medtech, diagnostics, and digital health companies, from the launch plan through adoption after FDA clearance.
For companies that need an operator and not only a diagnosis, Barbara also works inside the business as a fractional commercial executive on a defined mandate.
And for investors
Private equity and venture investors assessing adoption risk before an investment closes, and operating partners deciding which portfolio company receives the next dollar of commercial capital.
Adoption risk shows up in three places.
The work shows where to focus first.
Awareness
They do not enter the funnel, because they do not know the solution or when it applies.
Usability
They try it or install it, but it does not fit how care is actually delivered.
Trust
They evaluate, but do not believe enough to change what they do.
One clear next decision.
The adoption risk to prevent, the barrier to address, or the asset to investigate first, and where to invest next.
Twenty years inside healthcare commercialization.
Start with a Fit Check.
A short, free conversation that confirms there is enough evidence to run the diagnosis, and whether now is the right time.